Key points are not available for this paper at this time.
The escalating global crisis of antimicrobial resistance demands innovative therapeutic strategies that transcend conventional approaches. This comprehensive review examines the groundbreaking synergistic integration of silver nanoparticles (AgNPs) with silk proteins (fibroin and sericin from Bombyx mori) to create advanced nanocomposite materials for biomedical applications. While extensive literature exists for AgNPs and silk proteins individually, a limited number of studies have explored their synergistic combination. This review consolidates this fragmented knowledge to establish the foundational framework for an emerging field. The unique properties of silk proteins as natural reducing, stabilizing, and capping agents enable environmentally friendly AgNPs synthesis while creating intelligent therapeutic platforms with emergent properties. These hybrid materials demonstrate superior performance in terms of antimicrobial efficacy, biocompatibility, and accelerated wound healing compared to the individual components. The nanocomposites exhibit broad-spectrum activity against multidrug-resistant pathogens while maintaining exceptional biocompatibility and promoting tissue regeneration. This integration represents a promising evolution toward biomimetic therapeutic platforms that work in harmony with biological systems, offering sustainable solutions to contemporary healthcare challenges.
Pollini et al. (Sun,) studied this question.